NASDAQ:FEMY - Nasdaq - US31447E1055 - Common Stock - Currency: USD
FEMY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. FEMY has a bad profitability rating. Also its financial health evaluation is rather negative. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -159.02% | ||
ROE | -1057.44% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 66.24% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.89 | ||
Debt/FCF | N/A | ||
Altman-Z | -17.17 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.93 | ||
Quick Ratio | 0.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.8769
+0 (+0.17%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 16.79 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 14.29 | ||
P/tB | 14.72 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -159.02% | ||
ROE | -1057.44% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 66.24% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.89 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 83.92% | ||
Cap/Sales | 50.27% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.93 | ||
Quick Ratio | 0.54 | ||
Altman-Z | -17.17 |